about
Natural solution to antibiotic resistance: bacteriophages 'The Living Drugs'Escherichia coli in Europe: an overviewSubdiffusive motion of bacteriophage in mucosal surfaces increases the frequency of bacterial encounters.Bacteriophages and phage-derived proteins--application approachesImportance of prophages to evolution and virulence of bacterial pathogensBacteriophages for managing Shigella in various clinical and non-clinical settingsCharacterization of extended-host-range pseudo-T-even bacteriophage Kpp95 isolated on Klebsiella pneumoniaeIsolation and characterization of φkm18p, a novel lytic phage with therapeutic potential against extensively drug resistant Acinetobacter baumanniiThree New Escherichia coli Phages from the Human Gut Show Promising Potential for Phage TherapyBeyond phage therapy: virotherapy of protozoal diseasesIsolation and characterization of bacteriophages infecting nocardioforms in wastewater treatment plantDiversity of phage infection types and associated terminology: the problem with 'Lytic or lysogenic'.Complete genome sequence of the novel lytic avian pathogenic coliphage NJ01Comparative genomic analysis of bacteriophages specific to the channel catfish pathogen Edwardsiella ictaluri.Detection and quantification of Flavobacterium psychrophilum-specific bacteriophages in vivo in rainbow trout upon oral administration: implications for disease control in aquaculture.European regulatory conundrum of phage therapy.Enhancing the utility of existing antibiotics by targeting bacterial behaviour?Ecological basis for rational phage therapy.Bacteriophages as antimicrobial agents against major pathogens in swine: a reviewExperimental Phage Therapy for Burkholderia pseudomallei InfectionPhage Therapy - Everything Old is New AgainVirulent bacteriophages can target O104:H4 enteroaggregative Escherichia coli in the mouse intestineHigh Emergence of ESBL-Producing E. coli Cystitis: Time to Get Smarter in CyprusA Yersinia pestis-specific, lytic phage preparation significantly reduces viable Y. pestis on various hard surfaces experimentally contaminated with the bacterium.Oral Phage Therapy of Acute Bacterial Diarrhea With Two Coliphage Preparations: A Randomized Trial in Children From BangladeshLearning from bacteriophages - advantages and limitations of phage and phage-encoded protein applications.Lytic phages obscure the cost of antibiotic resistance in Escherichia coli.Effects of antibiotic resistance alleles on bacterial evolutionary responses to viral parasitesNovel alternatives to antibiotics: bacteriophages, bacterial cell wall hydrolases, and antimicrobial peptides.Engineered bacteriophage targeting gene networks as adjuvants for antibiotic therapyDecreasing Enterobacter sakazakii (Cronobacter spp.) food contamination level with bacteriophages: prospects and problemsModification of Escherichia coli-bacteriophage interactions by surfactants and antibiotics in vitro.Phage therapy and photodynamic therapy: low environmental impact approaches to inactivate microorganisms in fish farming plants.Vibrio vulnificus bacteriophage SSP002 as a possible biocontrol agent.Evaluation of the efficacy of chitosan nanoparticles loaded ΦKAZ14 bacteriophage in the biological control of colibacillosis in chickens.Call for a dedicated European legal framework for bacteriophage therapy.Recent advances in bacteriophage therapy: how delivery routes, formulation, concentration and timing influence the success of phage therapy.Phages in the global fruit and vegetable industry.From bench to bed and back again: phage therapy of childhood Escherichia coli diarrhea.Isolation and characterization of T7-like lytic bacteriophages infecting multidrug resistant Pseudomonas aeruginosa isolated from Egypt.
P2860
Q24563742-75179D25-CDF4-4E3A-87C0-4CB627F41D36Q27015697-9D238465-240B-4887-A90C-E40DBE1955CCQ27322154-7EDDEFE6-0566-42D6-A529-5623D878890DQ28082731-5A347BED-C604-4C2A-B68C-52FF67B36726Q28289474-188D52EA-F558-480B-9630-73483A620CD4Q28384795-4C1024FB-D62C-4D10-A74A-03B5C7808629Q28395611-B009336F-7F52-401C-AF45-299970601B35Q28484243-CEF35F93-48A6-4F71-B803-CD3FBE2A80C0Q28550170-8E9367B8-AC66-4A20-80AC-8D39C33E4EE9Q29396924-2537EF0B-7D4C-4B25-BA39-184B55570396Q34032584-7C572C0F-3FD5-45C1-A1F4-B6DC6C69A589Q34046319-5697D354-A82B-4BFC-85E7-6FA399FC1A1CQ34481776-5464BBAA-0041-49D8-92E3-C984B572A103Q34516096-7510E738-2376-42FD-8E1E-B12E573B8F22Q34595583-792B0AFA-8957-4C06-B8D8-35EF3E7C11A8Q34700022-81B35CDE-9D5E-4392-BBD3-B5BF6C7EBEA7Q35853204-63F329D6-3464-4D9D-A02F-309118A2DFA0Q35944299-D17DA327-AA94-4965-ABF6-B287B109A598Q35994120-CEC038F1-9D47-464F-91AB-BF23E7F6CF11Q36069790-F45D5243-B313-4582-ADCC-D16DDEF17D81Q36171271-C17A99FA-835F-479A-BAF4-9893F2F154D9Q36396212-BF44CB47-2E27-48D1-8513-FD7FDCCBB189Q36456613-1AF2B3C0-CCA8-46D4-8C55-92593CCF06DBQ36489653-565F13E7-9E38-4CBC-BB47-5E7C38DFD7DCQ36645103-2BD64668-0FCF-4EC2-82B5-18CDA823E029Q36676044-69FBB5C0-D96F-4E02-AC91-FD6AF24CCF75Q36756563-AE8BF3E5-8628-4067-9760-78DC92288631Q36966690-F0871332-536D-40BB-ADB1-A92135D2B4B0Q37048735-6202EF2D-1198-4AEF-B43F-6BE7E644D5D3Q37114251-571468CF-4821-4C98-94ED-4A17392427DDQ37273419-BA975C7A-2F35-4F73-8A50-17E4A3E3240DQ37387916-5748CDF3-2F9C-4D10-9090-D5593156BC58Q37389925-C390F3DE-4F0D-430A-B761-AD3AC4227139Q37545535-F5769459-99AC-4B80-9E62-39B09202939FQ37606227-840F160E-0562-47E6-9BF6-E81488CA2F3CQ37631618-15418AC5-D980-4139-80A5-A64A78368703Q37928694-775482FA-7CCA-48FC-AEE5-0FAAC1099A69Q38269723-063A2B1E-6ACB-42CD-999A-E1C0D733B804Q38838727-D0BF7002-BD46-412B-9802-F2ADFF304212Q38984331-59154F03-1916-4624-9BB9-DCD11036D9E2
P2860
description
2005 nî lūn-bûn
@nan
2005 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Phage therapy: the Escherichia coli experience.
@ast
Phage therapy: the Escherichia coli experience.
@en
Phage therapy: the Escherichia coli experience.
@nl
type
label
Phage therapy: the Escherichia coli experience.
@ast
Phage therapy: the Escherichia coli experience.
@en
Phage therapy: the Escherichia coli experience.
@nl
prefLabel
Phage therapy: the Escherichia coli experience.
@ast
Phage therapy: the Escherichia coli experience.
@en
Phage therapy: the Escherichia coli experience.
@nl
P356
P1433
P1476
Phage therapy: the Escherichia coli experience.
@en
P304
P356
10.1099/MIC.0.27849-0
P577
2005-07-01T00:00:00Z